In Vitroanticancer Activities of Anogeissus Latifolia, Terminalia
Total Page:16
File Type:pdf, Size:1020Kb
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.15.6423 In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleiferna RESEARCH ARTICLE In Vitro Anticancer Activities of Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleiferna Indian Plants Kawthar AE Diab1,2*, Santosh Kumar Guru2, Shashi Bhushan2, Ajit K Saxena2 Abstract The present study was designed to evaluate in vitro anti-proliferative potential of extracts from four Indian medicinal plants, namely Anogeissus latifolia, Terminalia bellerica, Acacia catechu and Moringa oleiferna. Their cytotoxicity was tested in nine human cancer cell lines, including cancers of lung (A549), prostate (PC-3), breast (T47D and MCF-7), colon (HCT-16 and Colo-205) and leukemia (THP-1, HL-60 and K562) by using SRB and MTT assays. The findings showed that the selected plant extracts inhibited the cell proliferation of nine human cancer cell lines in a concentration dependent manner. The extracts inhibited cell viability of leukemia HL-60 and K562 cells by blocking G0/G1 phase of the cell cycle. Interestingly, A. catechu extract at 100 µg/mL induced G2/M arrest in K562 cells. DNA fragmentation analysis displayed the appearance of a smear pattern of cell necrosis upon agarose gel electrophoresis after incubation of HL-60 cells with these extracts for 24h. Keywords: Anogeissus latifolia - terminalia bellerica - acacia catechu - moringa oleiferna - cytotoxicity - DNA ladder Asian Pac J Cancer Prev, 16 (15), 6423-6428 Introduction and antifungal activities (Caceres et al., 1992; Biswas et al., 2012; Krishnamurthy et al., 2015). Considering the There has been a long-standing interest in identification vast therapeutic potential of above mentioned medicinal of natural products and medicinal plants for developing plants, the present study was planned to investigate their new cancer therapeutics. India, represented by rich anti-proliferative potential in different panel of human culture, traditions, and natural biodiversity, offers a cancer cell lines. To get some insight into the cellular unique opportunity for researchers in drug discovery and mechanism of action of the extracts, the most active development (Brusotti et al., 2014). This country has 2 concentrations of the plants extracts were also studied of 18 hotspots of plant biodiversity in the world, namely for cell cycle arrest and apoptotic potential in human Eastern Himalaya and Western Ghats (Chitale et al., leukemia cell line. 2014). In the present study, we selected four medicinal plants namely Anogeissus latifolia, Terminalia bellerica, Materials and Methods Acacia catechu and Moringa oleiferna to explore their anticancer efficacy in human cancer cell lines. Stem bark Chemicals and reagents of Anogeissus latifolia has been extensively utilized in the The RPMI-1640 medium, Dulbecco’s modified treatment of various disorders like skin diseases, snake eagle’s medium (DMEM), fetal calf serum (FCS), trypsin, and scorpion bites, leprosy, diabetes, stomach diseases, gentamycin, penicillin, sulforhodamine blue (SRB), 3-(4, colic, cough, and diarrhea (Patil and Gaikwad, 2011). 5-dimethy- lthiazol-2-yl)-2, 5-diphenyl)-tetrazolium The fruit of Terminalia bellerica has been used for the bromide (MTT), ethidium bromide, propidium iodide (PI), treatment of anemia, asthma, cancer, colic, constipation, DNase-free RNase, proteinase K, dimethyl sulphoxide diarrhea, dysuria, headache, hypertension, inflammation, (DMSO), camptothecin, were purchased from Sigma- and rheumatism (Rashed et al., 2014). The bark and Aldrich (St. Louis, MO, USA). Ethylenediaminetetraacetic heartwood of Acacia catechu are widely used for the acid (EDTA), tris-base and phosphate buffered saline treatment of chronic fever, ulcer, cough, worm infestation, (PBS) were obtained from HiMedia Laboratories Pvt. poisonous bites, obesity, hepatomegaly, spleeno¬megaly, Ltd. (Mumbai, India). Trichloroacetic acid (TCA) was and problems related to skin, throat, tooth, and urinary procured from Merck Specialties Pvt. Ltd., (Mumbai, tract (Stohs and Bagchi, 2015). Various parts of Moringa India). oleifera such as leaves, roots, seed, bark, fruit, flowers and immature pods are used as cardiac and circulatory Extraction Process stimulants, and have been shown to have diuretic, The plants were harvested from herbal garden of antitumor, anti-inflammatory, antispasmodic, antibacterial, Indian Institute of Integrative Medicine (IIIM), Jammu, 1Genetics and Cytology Department, National Research Centre, Dokki, Giza, Egypt, 2Cancer Pharmacology Division, Indian Institute of Integrative Medicine, CSIR, Jammu-Tawi, Jammu and Kashmir, India *For correspondence: [email protected] Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 6423 Kawthar AE Diab et al India. The plants were identified and authenticated by The absorbance at wavelength 540 nm was read using a taxonomist of the IIIM. The extraction process of these microplate reader (Tecan, Switzerland). plants was procured from the National products Chemistry Division of the IIIM. Dried and powdered plants were MTT assay placed in a conical glass percolator, submerged in 95% Mitochondrial activity was evaluated by MTT assay ethanol or 50 % ethanol, and kept at room temperature as described earlier (Vega-Avila and Pugsley 2011). for 20h (Table 1). The extraction procedure was repeated This assay based on enzymatic reduction of the yellow four times and the percolate were collected and filtered. colored MTT dye to purple colored formazan crystals by Ethanol was distilled off from pooled percolate using a a variety of mitochondrial and cytosolic enzymes that are rotavapour under reduced pressure at 50°C. The final operational in viable cells. Briefly, HL-60 and K562 cells drying was done initially in vacuum desiccators and (5000 cells/well) were seeded in 100 µL of medium into finally lyophilized. The dried extracts were scrapped off 96-well plate and left to settle in a CO2 incubator. After and transferred to a wide mouth glass container. Nitrogen 60 min of incubation, the test material was added in each was blown in the container before capping and stored at well (100 μL/well) and the plate was incubated for 48 h. -20°C in a desiccator. Four hours before the end of incubation period, 20 μL of MTT solution (2.5 mg/mL in PBS) was added to each well Cell culture and treatment and re-incubated for 4h at 37°C. The plate was centrifuged Nine human cancer cell lines were obtained from with rotor for 96-well plate assembly (Beckman GS-6R, National Cancer Institute, Frederick, USA. The cell USA) at 3000 rpm for 15 min. Then, the supernatant lines were derived from different cancers including lung culture medium containing MTT was removed and 200 (A549), prostate (PC-3), breast (T47D and MCF-7), colon μL of DMSO were added to each well to dissolve the (HCT-16, Colo-205), and leukemia (THP-1, HL-60 and formazan crystals. The optical density (OD) of each well K562). All cell lines were routinely cultured in RPMI- was recorded using a microplate reader at a wavelength 1640 growth medium except MCF-7 cell line was cultured of 570 nm. The percentages of cell viability and growth in DMEM medium. Both growth media (pH 7.2) were inhibition were calculated according to the following supplemented with 10% FCS, 1% penicillin (100 U/mL) equations (Chanda et al., 2012). Cell viability (%)=[(OD and streptomycin (10 mg/mL), in tissue culture flask in of treated cells-OD of blank)/ (OD of control-OD of an incubator at 37°C with 95% relative humidity and 5% blank)×100]. Growth inhibition (%)100 – % Cell viability CO2 gas environment. The cells were harvested either by trypsinization (adherent cultures) or by centrifugation at Cell cycle analysis 1000 rpm for 5 min (suspension cultures). Stock solutions Flow cytometry was used to analyze cell cycle (20 mg/mL) of the extracts were dissolved in DMSO and distribution according to the standard procedures (Saxena serially diluted with complete growth medium containing et al., 2010). Briefly, HL-60 and K562 cells (2×106 / mL/6 50 µg/mL of gentamycin to the desired concentrations (10, well plate) were treated with plant extracts at 50 and 100 30, 50, 70 and 100 µg/mL). Untreated control cultures μg/mL for 24 h. The cells were harvested and centrifuged received only the vehicle (DMSO<1%). at 400g for 5 min. The supernatant was discarded and the pellet was washed twice with 2 mL of PBS. The cells In vitro cytotoxicity screening were fixed overnight in chilled 70% ethanol at 4°C and Sulforhodamine blue (SRB) assay: Measurement of then subjected to RNase digestion (400 μg/mL) at 37°C the cellular protein content was performed using the SRB for 1h. Finally, the cells were stained with PI (10 μg/ assay as described earlier (Vichai and Kirtikara, 2006). mL) for 30 min in dark and analyzed immediately for Briefly, seven adherent cultures namely A459, PC3, MCF- DNA contents on a Flow Cytometer FACS Diva (Becton 7, T47D, Colo-205, HCT-16 and THP-1 were harvested Dickinson, Franklin Lakes, NJ, USA). The cell cycle in log phase using trypsinization (0.05% trypsin and histograms were analyzed using the ModFit LT™ 3.2.1 0.02% EDTA, in PBS) and the cells were counted using a software packages (Verity Software House Inc., Topsham, hemocytometer. The cells were seeded into 96-well plates ME). In this program, debris and single cell populations at density 1000 cells/100μL/well excepting Colo-205 cells were gated out using two parameter histogram of FL2-A were seeded at density 1500 cells/well in 100μL medium versus FL2-W. into 96 well plate. After 24h, the medium was aspirated and the cells were exposed to 100 μL/well of freshly DNA ladder assay prepared medium containing test materials at desired HL-60 cells (2×106 cells/mL in 6-well plate) were concentrations for 48 h. At the end of exposure time, 50 harvested after 24h treatment with the selected plant μL of ice-cold 50% TCA was added to each well and left extracts at 50 and 100 μg/mL.